SCHEMBL19852539

SCHEMBL19852539

COC(COc1ccc2cccnc2c1)OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.56
PDE10A Q9Y233 1/20 0.54
ALDH1A1 P00352 3/20 0.47
PDGFRB P09619 2/20 0.45
PDGFRA P16234 2/20 0.45
P2RY14 Q15391 2/20 0.44
CACNA2D1 P54289 1/20 0.44
MEN1 O00255 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
NR4A2 P43354 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDR P35968 1/20 0.41
CYP2D6 P10635 1/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1953356 0.88 ALDH1A1 (0.49) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL4215653 0.79 CYP3A4 (0.64) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL30181876 0.79 CYP3A4 (0.64) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL23412137 0.79 CYP3A4 (0.68) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL619653 0.79 RAB9A (0.59) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL29831778 0.79 RAB9A (0.59) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL10090158 0.78 CYP3A4 (0.59) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL29096117 0.77 PDGFRB (0.62) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
Benzene SCHEMBL27716393 0.77 CYP3A4 (0.61) CYP3A4PDE10AALDH1A1PDGFRBPDGFRA
SCHEMBL19683350 0.77 AGXT (0.42) CYP1A2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed